Figure 1.
Three-month interval subjective assessment of erenumab therapy. The vast majority of the patients reported an improvement of all the parameters shown.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.